LG Life Science Tops R&D Investment List of Korea-Listed Pharmas
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Of the 37 local Korean pharmas listed on Korea's main KOSPI stock market, LG Life Science topped local pharmas in R&D investment last year in both scale and in proportion to its sales, according to a report released by a lawmaker in an Oct. 6 National Assembly session